Casein kinase 2-interacting protein 1 (CKIP-1) is a negative regulator for bone formation. Previously, using bioinformatics analysis, CKIP-1 has been predicted to serve the role of target gene of miR-98-5p. In the present study, the potential role of miR-98-5p in regulating osteoblast differentiation through CKIP-1 was investigated. Following pre-treatment with microRNA (miR)-98-5p agomir or miR-98-5p antagomir, MC3T3-E1 cells were cultured in an osteoinductive medium. Subsequently, the expression of miR-98-5p, CKIP-1 and levels of osteoblast differentiation markers, including alkaline phosphatase, matrix mineralization, osteocaicin, collagen type I, runt-related transcription factor 2 and osteopontin were assayed. Using a dual-luciferase reporter assay, it was demonstrated that CKIP-1 was the target gene of miR-98-5p. miR-98-5p was upregulated as a result of treatment with miR-98-5p agomir and promoted osteoblast differentiation. Conversely, miR-98-5p antagomir inhibited miR-98-5p expression and osteoblast differentiation. miR-98-5p targeted CKIP-1 by binding to its 3'-untranslated region. Furthermore, miR-98-5p overexpression decreased the protein levels of CKIP-1 and inhibition of miR-98-5p increased the protein levels of CKIP-1. The results of the present study indicated that CKIP-1 was a target gene of miR-98-5p and that miR-98-5p regulated osteoblast differentiation in MC3T3-E1 cells by targeting CKIP-1.
Introduction
Osteoblasts are the differentiated cell types responsible for bone formation, originating from resident bone marrow-derived mesenchymal stem cells (BMSCs) or bone marrow stromal cells (1, 2) . Regulation of osteoblast differentiation and activity has been hypothesized as a prospective therapy of bone injury and loss. In order to develop such therapies, novel molecular targets that regulate osteoblast differentiation and activity need to be identified.
Casein kinase 2-interacting protein 1 (CKIP-1) is a negative regulator for bone formation under physiological conditions. In CKIP-1 knockout mice, bone mineral density and mass increased markedly, as did the activity of osteoblasts (3) . CKIP-1 interacts with mothers against decapentaplegic homolog ubiquitination regulatory factor 1 to induce negative regulation in bone formation (4) . In addition, as a result of inhibition of CKIP-1 expression in osteoblasts, bone mass increased markedly and the rate of bone formation accelerated (5, 6) .
MicroRNAs (miRs), classified as small noncoding RNAs, regulate gene expression by targeting the 3'-untranslated region (UTR) of mRNA (7, 8) . MiRs serve a role in cell development and growth processes, including cell proliferation, apoptosis and differentiation (9, 10) . Previous studies have identified miRNAs that regulate osteoblast differentiation (11, 12) . CKIP-1 is a negative regulator for osteoblast differentiation and therefore, an miR targeting CKIP-1 may improve osteoblast differentiation.
The authors of the present study previously demonstrated that CKIP-1 is a putative target gene of miR-98-5p using bioinformatics analysis (unpublished data). It has been hypothesized that miR-98-5p may be involved in osteoblast differentiation through regulation of CKIP-1 expression. In the present study, mouse MC3T3-E1 pre-osteoblasts were used to investigate the potential role and underlying mechanism of miR-98-5p-mediated regulation of osteoblast differentiation.
Materials and methods
Cell culture. Mouse pre-osteoblast cell line, MC3T3-E1 (Institute of Basic Medicine of Peking Union Medical College, Beijing, China), was cultured with α-minimal essential medium (α-MEM; Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 1% penicillin (Thermo Fisher Scientific, Inc.) at 37˚C in a humidified atmosphere containing 5% CO 2 . For all experiments, MC3T3-E1 cells were seeded at the density of 2.5x10 4 cells/cm 2 in cell culture dishes and cultivated until miR-98-5p promotes osteoblast differentiation in MC3T3-E1 cells by targeting CKIP-1 80% confluence was reached. To induce osteoblast differentiation, confluent cells were cultured at 37˚C in a humidified atmosphere containing 5% CO 2 , in an osteoinductive medium supplemented with 10% FBS, 50 µg/ml ascorbic acid, 5 mM sodium b-glycerophosphate and 2 mM/l glutamine, which was replaced once every three days (13) .
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cultured cells were lysed by TRIzol ® reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and total RNA was isolated according to the manufacturer's protocol. cDNA was synthesized using the TIANScript Ⅱ RT kit (Tiangen Biotech Co., Ltd., Beijing, China). For miRNA expression analysis, cDNA synthesis was performed using the TaqMan MicroRNA reverse transcription kit (Applied Biosystems; Thermo Fisher Scientific, Inc.). qPCR was performed to detect mRNA levels of osteocalcin (OCN), collagen type I (Col I) and GAPDH or miR-98-5p levels using SYBR Green I PCR Mix (Beijing CoWin Biotech Co., Ltd., Beijing, China) according to the manufacturer's protocol. Primer sequences are listed in Table I and the primers for miR-98-5p (miRBase accession no. MIMAT0000545) were provided by Guangzhou RiboBio Co., Ltd. (Guangzhou, China). The following thermocycling conditions were used for the PCR: Initial denaturation at 94˚C for 180 sec; 40 cycles of 94˚C for 15 sec, annealing at 60˚C for 30 sec, and extension at 72˚C for 30 sec. Relative expression was normalized to mRNA levels of GAPDH using the 2 -ΔΔCq method (14) .
Detection of osteoblast differentiation. To investigate the role of miR-98-5p expression on osteoblast differentiation, confluent MC3T3-E1 cells were pre-treated with 100 nM miR-98-5p agomir, antagomir, agomir control or antagomir control (Guangzhou RiboBio Co., Ltd.) for 24 h at 37˚C in α-MEM culture medium. Control MC3T3-E1 cells were cultured in α-MEM culture medium only, without pre-treatment. Cells were subsequently cultured in osteoinductive medium for 3, 5, 7 and 14 days, as described above. Cells were harvested, washed with a PBS and lysed with a lysis buffer (10 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 250 mmol/l sucrose, 5 mmol/l Tris-HCl, 0.1%TritonX-100, pH 7.5). Alkaline phosphatase (ALP) activity of lysates was measured using the ALP Activity Assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) at 25˚C using the p-nitrophenyl phosphate method according to manufacturer's protocol. Matrix mineralization was detected with Alizarin red S staining. Briefly, cells were fixed with 70% ethanol for 30 min at room temperature and washed with PBS. Subsequently, cells were stained with Alizarin red S solution (40 mM) for 15 min at room temperature. Excessive stain was washed off with PBS. Alizarin red S-stained mineral deposits were extracted and dissolved in 0.1 N NaOH and the absorbance was measured at a wavelength of 540 nm using an ELISA reader (Multiskan GO 1510; Thermo Fisher Scientific, Inc.).
Western blot analysis. Following washing twice with PBS, cells were lysed in ice-cold radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Nanjing, China). Protein concentration was quantified using bicinchoninic acid method. Target prediction of miR-98-5p. The target mRNA of miR-98-5p was predicted by searching the online databases TargetScan (http://www.targetscan.org/) and miRDB (http://www.mirdb.org/). mRNAs with a 3'-untranslated region (3'-UTR) that matched the 2-7 base of the miR-98-5p 5'-terminal region with high thermodynamic stability were selected. Subsequently, CKIP-1 was predicted as a target mRNA of miR-98-5p.
Dual-luciferase reporter assay. The 3'-UTR region of CKIP-1, containing the binding site of miR-98-5p, was amplified and subcloned into a pmiR-RB-REPORT plasmid (Guangzhou RiboBio Co., Ltd., Guangzhou, China), according to the manufacturer's protocol. The corresponding mutated 3'UTR of CKIP-1 was also amplified and subcloned into the plasmid. Human 293 cells (the 293 cells in the present study were only used for the luciferase assay) were seeded into 6-well cell culture plates at 1x10 5 cells/well and subsequently transfected with miR-98-5p mimics (sequence, UGA GGU AGU AAG UUG UAU UGU U) or miR-98NC (sequence, UCA CAA CCU CCU AGA AAG AGU AGA; Guangzhou RiboBio Co., Ltd.) at a final concentration of 50 nM for 24 h. Subsequently, the pmiR-RB CKIP-1 3'-UTR plasmid was transfected into 293 cells at concentration of 1 ng/µl using a Lipofectamine ® 2000 transfection reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. A total of 2 days following transfection, the luciferase activity of the cells was determined using a dual-luciferase reporter assay kit (Promega Corporation, Madison, WI, USA) and was normalized to Renilla luciferase activity, according to the manufacturer's protocol.
Statistical analysis. All data are presented as the mean ± standard deviation from three separate experiments (n=3). Data was tested for normal distribution using Shapiro-Wild test and differences between groups were analyzed using one-way analysis of variance and determined by Duncan's multiple range test. Statistical analysis was performed using SPSS software (version 18; SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
MiR-98-5p promotes osteoblast differentiation. In order to determine whether miR-98-5p is involved in regulation of osteoblast differentiation, the expression of miR-98-5p in MC3T3-E1 cells following osteoblast differentiation was detected by RT-qPCR. In the present study, following culture of MC3T3-E1 cells in osteoinductive medium, alkaline phosphatase activity and matrix mineralization of cells was elevated at each time point ( Fig. 1A and B ), indicating that MC3T3-E1 cells differentiated into osteoblasts. The expression level of miR-98-5a was also significantly elevated at each time point following osteoblast differentiation (all P<0.01; Fig. 1C ), which suggested that miR-98-5p may serve a role in osteoblast differentiation.
To confirm the role of miR-98-5p in the regulation of osteoblast differentiation, MC3T3-E1 cells were treated with miR-98-5p agomir or miR-98-5p antagomir and the treatments increased and decreased the miR-98-5p expressions levels in MC3T3-E1 cells, respectively (Fig. 1D) . Furthermore, the present study demonstrated that miR-98-5p agomir markedly increased ALP activity ( Fig. 2A ) and matrix mineralization (Fig. 2B ), at each time point compared with the respective control groups. Elevated mRNA expressions of Col I and OCN (Fig. 3) , and increased protein levels of Runx2 and OPN (Fig. 4) were observed in cells following treatment with miR-98-5p, at each time point compared with the respective control groups. Conversely, miR-98-5p antagomir significantly inhibited ALP activity and matrix mineralization, and decreased expression levels of OCN, Col I, Runx2 and OPN (Figs. 2-4) . Table I . Primer sequences for quantitative polymerase chain reactions. CKIP-1 is a target gene of miR-98-5p. Subsequently, the expression of the target gene of miR-98-5p that contributed to the regulation of osteoblast differentiation was investigated and CKIP-1. To validate the interaction between miR-98-5p and CKIP-1, a dual-luciferase reporter assay was performed in the present study. The results demonstrated that overexpression of miR-98-5p significantly decreased the luciferase activity in cells transfected with pmiR-RB CKIP-1 3'-UTR, whereas it demonstrated no effect on pmiR-RB-mut CKIP-1 3'-UTR (Fig. 5B ). Following treatment with miR-98-5p agomir or miR-98-5p antagomir, qPCR and western blot analysis demonstrated that miR-98-5p overexpression decreased mRNA and protein levels of CKIP-1, whereas inhibition of miR-98-5p increased mRNA and protein expression of CKIP-1 (Fig. 5C ). The aforementioned results indicate that CKIP-1 is the target gene of miR-98-5p.
Primer sequence
miR-98-5p regulates osteoblast differentiation by targeting CKIP-1. The present study investigated the mechanism underlying miR-98-5p-mediated regulation of osteoblast differentiation. The association between overexpression and inhibition of miR-98-5p and osteoblast differentiation was investigated. In the present study, following treatment with miR-98-5p agomir, osteoblast differentiation-associated markers, including ALP, matrix mineralization, OCN, Col I, Runx2 and OPN were markedly elevated in MC3T3-E1 cells (Figs. 2-4) . Conversely, treatment with miR-98-5p antagomir decreased the levels of osteoblast differentiation-associated markers (Figs. 2-4) . 
Discussion
ALP, OPN, Runx 2, OCN and matrix mineralization are markers of osteogenic differentiation and therefore they have been previously assayed to evaluate osteoblast differentiation (15) (16) (17) (18) (19) . Col I, a collagen identified in bone matrices, is also a maker of osteogenesis (20) . Therefore, in the present study, ALP, OPN, Runx 2, OCN, Col I and matrix mineralization were selected as indices of osteoblast differentiation.
In the present study, miR-98-5p served the role of regulator of osteoblast differentiation by downregulating the expression of CKIP-1, a negative regulator of osteoblast differentiation. The results of the present study indicated that the expression of miR-98-5p was increased during osteoblast differentiation and miR-98-5p overexpression significantly promoted osteoblast differentiation of MC3T3-E1 cells. Downregulated expression of miR-98-5p negatively regulated osteoblast differentiation. Using a dual-luciferase reporter assay, a direct interaction between miR-98-5p and the 3'-UTR region of CKIP-1 was verified. In the present study, miR-98-5p negatively regulated mRNA and protein expression levels of CKIP-1 in MC3T3-E1 cells. Transfection with miR-98-5p agomir or antagomir disrupted the interaction between CKIP-1 and osteoblast differentiation. The present study demonstrated that miR-98-5p regulates CKIP-1 expression.
The role of miR-98 in different cellular processes in various cell types has been previously investigated. miR-98 repressed the expression of cytokine-inducible Src homology 2-containing protein in cholangiocytes and was involved in responses to microbial challenge and inflammation (21) . MiR-98 also negatively regulated interleukin-10 production and endotoxin tolerance in macrophages following stimulation with lipopolysaccharide (22) . miR-98 is a tumor suppressive miRNA, knockdown of which leads to a reduction of 1,25-vitamin D anti-growth effect of prostate cancer and overexpression of miR-98 suppressed prostate cancer cell growth (23) . miR-98 inhibits human ovarian cancer stem cell proliferation via retinoblastoma-associated protein-E2F transcription factor pathway and suppresses hepatocellular carcinoma by targeting Sal-like protein 4 and collagen triple helix repeat containing 1 (24) (25) (26) . Currently, a limited amount of data is available regarding miR-98-mediated regulation of osteoblast differentiation.
In the present study, miR-98-5p was involved in the regulation of osteoblast differentiation through targeting and regulating CKIP-1 expression. The results of the present study indicated that CKIP-1 was a target gene of miR-98-5p, through which miR-98-5p regulated osteoblast differentiation in MC3T3-E1 cells.
CKIP-1 regulates a number of processes, including cell proliferation, differentiation and apoptosis. CKIP-1 also serves a role in numerous types of cancer, including colon and breast cancers, and human osteosarcoma. Knockdown of CKIP-1 promotes proliferation of NHL cells by altering the interaction with RAC-alpha serine/threonine-protein kinase (Akt) (27) . CKIP-1 inhibits macrophage proliferation through activation of Akt (28) . Furthermore, CKIP-1 is a negative regulator of bone formation. In a mouse model, CKIP-1 knockout counteracted osteoporosis induced by stimulation with microgravity (29). CKIP-1 silencing with small interfering RNA promotes bone formation in a rat model, inhibits apoptosis, however promotes osteogenic differentiation of cultured BMSCs (30) .
In conclusion, the present study demonstrated that inhibition of CKIP-1 by miR-98-5p overexpression significantly promoted osteoblast differentiation. Overexpression of CKIP-1 induced by inhibition of miR-98-5p suppressed osteoblast differentiation. The results of the present study indicated that miR-98-5p regulated osteoblast differentiation in MC3T3-E1 cells by targeting CKIP-1. Figure 5 . Verification that CKIP-1 is a target gene of miR-98-5p. (A) Schematic diagram of miR-98-5p target site in the 3'-UTR of CKIP-1 mRNA. (B) Dual-luciferase reporter assay to detect the interaction between miR-98-5p and the 3'-UTR of CKIP-1. CKIP-1 (C) mRNA and (D) protein expression levels. Data are presented as the mean ± standard deviation. ** P<0.01. UTR, untranslated region; CKIP-1, casein kinase 2-interacting protein 1; mmu, Mus musculus; Mut, mutant.
